Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake.
Recent reports have demonstrated that conjugated linoleic acid (CLA) has effects on body fat accumulation. In our previous work, CLA reduced body fat accumulation in mice fed either a high-fat or low-fat diet. Although CLA feeding reduced energy intake, the results suggested that some of the metabolic effects were not a consequence of the reduced food intake. We therefore undertook a study to determine a dose of CLA that would have effects on body composition without affecting energy intake. Five doses of CLA (0.0, 0.25, 0.50, 0.75, and 1.0% by weight) were studied in AKR/J male mice (n = 12/group; age, 39 days) maintained on a high-fat diet (%fat 45 kcal). Energy intake was not suppressed by any CLA dose. Body fat was significantly lower in the 0.50, 0.75, and 1.0% CLA groups compared with controls. The retroperitoneal depot was most sensitive to the effects of CLA, whereas the epididymal depot was relatively resistant. Higher doses of CLA also significantly increased carcass protein content. A time-course study of the effects of 1% CLA on body composition showed reductions in fat pad weights within 2 wk and continued throughout 12 wk of CLA feeding. In conclusion, CLA feeding produces a rapid, marked decrease in fat accumulation, and an increase in protein accumulation, at relatively low doses without any major effects on food intake.
DeLany
J P
JP
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge 70808, Louisiana, USA. delanyjp/@mhs.pbrc.edu
Blohm
F
F
Truett
A A
AA
Scimeca
J A
JA
West
D B
DB
D000273:Adipose Tissue / Q000187:drug effects*; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects*; D007328:Insulin / Q000097:blood; D020738:Leptin; D019787:Linoleic Acid / Q000737:chemistry / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D051379:Mice; D008806:Mice, Inbred AKR; D011506:Proteins / Q000032:analysis; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D013997:Time Factors; D014617:Vacuoles / Q000648:ultrastructure
D007328:Insulin; D020738:Leptin; D011506:Proteins; D019787:Linoleic Acid